Biomonitoring of lake sediments using benthic macroinvertebrates

The Water Framework Directive (2000/60/EC) is an innovative piece of legislation aimed at protecting the quality of all continental and coastal waters in Europe through an ecological evaluation of the ecosystems. Since it is widely acknowledged that the greater the ecological realism the greater the difficulty of its definition, we describe the different uses of benthic organisms as a tool for assessing the quality of sediment in lakes. We review the responses from single species to the community. We focus on studies in the laboratory and in the field, and we also critically consider the use of predictive models for these evaluations. Our discussion of the information collected underlines the importance of the relation between sensitivity of single species and contaminants. Moreover, the recent approach in developing mechanistic models to predict the response of natural communities seems to be particularly powerful for community ecology, and we strongly recommend more effort along these lines

Collective behaviour without collective order in wild swarms of midges

Collective behaviour is a widespread phenomenon in biology, cutting through a huge span of scales, from cell colonies up to bird flocks and fish schools. The most prominent trait of collective behaviour is the emergence of global order: individuals synchronize their states, giving the stunning impression that the group behaves as one. In many biological systems, though, it is unclear whether global order is present. A paradigmatic case is that of insect swarms, whose erratic movements seem to suggest that group formation is a mere epiphenomenon of the independent interaction of each individual with an external landmark. In these cases, whether or not the group behaves truly collectively is debated. Here, we experimentally study swarms of midges in the field and measure how much the change of direction of one midge affects that of other individuals. We discover that, despite the lack of collective order, swarms display very strong correlations, totally incompatible with models of noninteracting particles. We find that correlation increases sharply with the swarm's density, indicating that the interaction between midges is based on a metric perception mechanism. By means of numerical simulations we demonstrate that such growing correlation is typical of a system close to an ordering transition. Our findings suggest that correlation, rather than order, is the true hallmark of collective behaviour in biological systems.Comment: The original version has been split into two parts. This first part focuses on order vs. correlation. The second part, about finite-size scaling, will be included in a separate paper. 15 pages, 6 figures, 1 table, 5 video

Finite-size scaling as a way to probe near-criticality in natural swarms

Collective behaviour in biological systems is often accompanied by strong correlations. The question has therefore arisen of whether correlation is amplified by the vicinity to some critical point in the parameters space. Biological systems, though, are typically quite far from the thermodynamic limit, so that the value of the control parameter at which correlation and susceptibility peak depend on size. Hence, a system would need to readjust its control parameter according to its size in order to be maximally correlated. This readjustment, though, has never been observed experimentally. By gathering three-dimensional data on swarms of midges in the field we find that swarms tune their control parameter and size so as to maintain a scaling behaviour of the correlation function. As a consequence, correlation length and susceptibility scale with the system's size and swarms exhibit a near-maximal degree of correlation at all sizes.Comment: Selected for Viewpoint in Physics; PRL Editor's Suggestio

Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studies

Background The goal of hepatorenal syndrome type 1 (HRS-1) treatment is to improve renal function. Terlipressin, a synthetic vasopressin analogue, is a systemic vasoconstrictor used for the treatment of HRS-1, where it is available. Aim To compare the efficacy of terlipressin plus albumin vs. placebo plus albumin in patients with HRS-1. Methods Pooled patient-level data from two large phase 3, randomised, placebo-controlled studies were analysed for HRS reversal [serum creatinine (SCr) value ≤133 μmol/L], 90-day survival, need for renal replacement therapy and predictors of HRS reversal. Patients received intravenous terlipressin 1–2 mg every 6 hours plus albumin or placebo plus albumin up to 14 days. Results The pooled analysis comprised 308 patients (terlipressin: n = 153; placebo: n = 155). HRS reversal was significantly more frequent with terlipressin vs. placebo (27% vs. 14%; P = 0.004). Terlipressin was associated with a more significant improvement in renal function from baseline until end of treatment, with a mean between-group difference in SCr concentration of −53.0 μmol/L (P \u3c 0.0001). Lower SCr, lower mean arterial pressure and lower total bilirubin and absence of known precipitating factors for HRS were independent predictors of HRS reversal and longer survival in terlipressin-treated patients. Conclusions Terlipressin plus albumin resulted in a significantly higher rate of HRS reversal vs. albumin alone in patients with HRS-1. Terlipressin treatment is associated with improved renal function

31p-NMR spectroscopy of rat liver during simple storage or continuous hypothermic perfusion

The ATP content and intracellular pH (pH(i)) of isolated rat liver before, during, and after cold preservation in either UW-lactobionate (UW, n=10) or Euro-Collins (EC, n=8) solutions were monitored using phosphorus-31 nuclear magnetic resonance ((31)P-NMR) spectroscopy. The (31)P-NMR spectra were obtained on a 4.7-Tesla system operating at 81 MHz. Fructose metabolism, liver enzyme release, O(2) consumption, and rat survival after liver transplantation were also evaluated. During simple cold storage (SCS), the ATP level declined to undetectable levels with both preservation solutions while the pH(i) declined to approximately 7.0. In contrast, during continuous hypothermic perfusion (CHP), hepatic ATP levels remained measurable during the 24-hour EC preservation and actually increased significantly (p>0.01) during UW preservation. After reperfusion at 37°C with Krebs-lactate, the SCS livers treated with EC differed significantly from the UW livers in terms of their ATP and pH(i) as well as their response to a fructose challenge. In contrast, livers undergoing CHP demonstrated similar behaviors with both solutions. These results demonstrate an increase in the hepatic ATP content during CHP which occurs with UW but is not seen with EC. On the other hand, only livers that were simply stored with UW achieved significant survival after transplant, while CHP livers were affected by vascular damage as demonstrated by fatal thrombosis after transplant. These data suggest that ATP content is not the only determinant of good liver function although a system of hypothermic perfusion might further improve liver preservation efficacy should injury to vascular endothelium be avoided

The hepatotropic influence of cyclosporine

The effect of cyclosporine on liver regeneration has been investigated in 25 dogs that underwent an end-to-side portacaval shunt (Eck fistula) followed by 4 days continuous infusion of the drug into the left branch of the portal vein. Three different cyclosporine infusion rates were used: 0.06, 0.6, and 4.0 mg/kg/day. Control animals received the intravenous vehicle of cyclosporine at the same rate as the treated animals; a second control group received insulin, 0.42 units/kg/day. Hepatocyte 3H-thymidine-labeled mitoses (index of hyperplasia) and hepatocyte volume (index of hypertrophy) were studied in the left (infused) and right (control) lobes in each animal. Cyclosporine vehicle had no measurable effect on hepatocytes that suffered typical atrophy and moderate increase in mitotic index after the Eck fistula. Cyclosporine infusion stimulated cell renewal significantly and restored hepatocyte size in the infused lobes with a dose-response relation. Similar positive effects were observed in the right (nonperfused) lobes, although they were less than those in the left (infused) lobes. This was because of an unmistakable spillover of cyclosporine from the infused lobes, especially in the large-dose group. No sign of hepatotoxicity was detected at any cyclosporine infusion rate. Cyclosporine has a remarkable hepatotropic effect that may be helpful in the context of liver transplantation

Revision of type and non-type material assigned to the genus Orthocladius by Goetghebuer (1940–1950), deposited in the Royal Belgian Institute of Natural Sciences (Diptera: Chironomidae)

Selected type and non-type material belonging to the genus Orthocladius van der Wulp, 1874 (Diptera: Chironomidae) sensu G OETGHEBUER (1940\u20131950), deposited in the Royal Belgian Institute of Natural Sciences (RBINS), originally comprising specimens dry pinned or stored in isinglass, were mounted on microscope slides and re-examined. Other chironomids present in the RBINS collection belonging to other genera were also examined. Fifty slides were prepared and identified to species, or to generic level when the condition of the specimens did not allow species identification. The following types, representing taxa formerly considered as nomina dubia, were examined and the concerned species are stated here as valid: Georthocladius collarti (Goetghebuer, 1941) comb. nov., Georthocladius scaturiginis (Goetghebuer, 1940) comb. nov., Lapposmittia succinea (Goetghebuer, 1942) comb. nov., Orthocladius (Euorthocladius) tolleti Goetghebuer, 1944 (new subgenus placement), Orthocladius (Orthocladius) timoni Goetghebuer & Timon-David, 1939, Pseudorthocladius hockaiensis (Goetghebuer, 1933). Orthocladius (Orthocladius) mitisi Goetghebuer, 1938, previously stated as junior synonym of Orthocladius (Orthocladius) glabripennis (Goetghebuer, 1921), is reinstated as valid species. The following new synonyms are proposed: Georthocladius (Georthocladius) collarti = Parachaetocladius retezati Albu, 1972: 19, syn. nov.; Cricotopus (Paratrichocladius) rufiventris (Meigen, 1830) = Orthocladius franzi Goetghebuer, 1949, syn. nov.; Cricotopus (Paratricho-cladius) skirwithensis Edwards, 1929 = Orthocladius nigritus Goetghebuer, 1938, syn. nov. = Paratrichocladius spiesi Ashe & O\u2019Connor, 2012; Hydrobaenus distylus (Potthast, 1914) = Orthocladius antennalis Goetghebuer, 1944, syn. nov. Lecto-types of Orthocladius collarti Goetghebuer, 1941, Orthocladius antennalis Goetghebuer, 1944, Orthocladius timoni Goetghebuer & Timon-David, 1939, and Orthocladius hockaiensis Goetghebuer, 1933 are designated. Non-type material assigned to Orthocladius was also mounted on slides and identified. Although a list of the non-Orthocladius taxa is also provided, no taxonomic changes are proposed for the latter

Response of chironomid species (Diptera, Chironomidae) to water temperature: effects on species distribution in specific habitats

The response of 443 chironomid species to water temperature was analyzed, with the aim of defining their thermal optimum, tolerance limits and thermal habitat. The database included 4442 samples mainly from Italian river catchments collected from the 1950s up to date. Thermal preferences were calculated separately for larval and pupal specimens and for different habitats: high altitude and lowland lakes in the Alpine ecoregion; lowland lakes in the Mediterranean ecoregion; heavily modified water bodies; kryal, krenal, rhithral and potamal in running waters. Optimum response was calculated as mean water temperature, weighted by species abundances; tolerance as weighted standard deviation; skewness and kurtosis as 3rd and 4th moment statistics. The responses were fitted to normal uni- or plurimodal Gaussian models. Cold stenothermal species showed: i) unimodal response, ii) tolerance for a narrow temperature range, iii) optima closed to their minimum temperature values, iv) leptokurtic response. Thermophilous species showed: i) optima at different temperature values, ii) wider tolerance, iii) optima near their maximum temperature values, iv) platikurtic response, often fitting a plurimodal model. As expected, lower optima values and narrower tolerance were obtained for kryal and krenal, than for rhithral, potamal and lakes. Thermal response curves were produced for each species and were discussed according to species distribution (i.e. altitudinal range in running water and water depth in lakes), voltinism and phylogeny. Thermal optimum and tolerance limits and the definition of the thermal habitat of species can help predicting the impact of global warming on freshwater ecosystems

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

Peginterferon plus ribavirin achieves sustained virological response (SVR) in fewer than half of patients with genotype 1 chronic hepatitis C virus infection treated for 48 weeks. We tested the efficacy of boceprevir, an NS3 hepatitis C virus oral protease inhibitor, when added to peginterferon alfa-2b and ribavirin. In part 1 of this trial, undertaken in 67 sites in the USA, Canada, and Europe, 520 treatment-naive patients with genotype 1 hepatitis C virus infection were randomly assigned to receive peginterferon alfa-2b 1·5 μg/kg plus ribavirin 800–1400 mg daily for 48 weeks (PR48; n=104); peginterferon alfa-2b and ribavirin daily for 4 weeks, followed by peginterferon alfa-2b, ribavirin, and boceprevir 800 mg three times a day for 24 weeks (PR4/PRB24; n=103) or 44 weeks (PR4/PRB44; n=103); or peginterferon alfa-2b, ribavirin, and boceprevir three times a day for 28 weeks (PRB28; n=107) or 48 weeks (PRB48; n=103). In part 2, 75 patients were randomly assigned to receive either PRB48 (n=16) or low-dose ribavirin (400–1000 mg) plus peginterferon alfa-2b and boceprevir three times a day for 48 weeks (low-dose PRB48; n=59). Randomisation was by computer-generated code, and study personnel and patients were not masked to group assignment. The primary endpoint was SVR 24 weeks after treatment. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00423670. Patients in all four boceprevir groups had higher rates of SVR than did the control group (58/107 [54%, 95% CI 44–64], p=0·013 for PRB28; 58/103 [56%, 44–66], p=0·005 for PR4/PRB24; 69/103 [67%, 57–76], p<0·0001 for PRB48; and 77/103 [75%, 65–83], p<0·0001 for PR4/PRB44; vs 39/104 [38%, 28–48] for PR48 control). Low-dose ribavirin was associated with a high rate of viral breakthrough (16/59 [27%]), and a rate of relapse (six of 27 [22%]) similar to control (12/51 [24%]). Boceprevir-based groups had higher rates of anaemia (227/416 [55%] vs 35/104 [34%]) and dysgeusia (111/416 [27%] vs nine of 104 [9%]) than did the control group. In patients with untreated genotype 1 chronic hepatitis C infection, the addition of the direct-acting antiviral agent boceprevir to standard treatment with peginterferon and ribavirin after a 4-week lead-in seems to have the potential to double the sustained response rate compared with that recorded with standard treatment alone. Merck